Development programme

Our current development pipeline includes:

• respiratory rate counters
• lung cancer screening
• diagnosis of asthma and COPD
• monitoring of asthma and COPD
• sleep apnoea screening

The development programmes include clinical trials to demonstrate clinical benefit of the products and to support future marketing and sales.

Respiratory Rate Counter

Respiration rate is acknowledged as being an important vital sign that can alert healthcare professionals to a deterioration in the condition of a patient in a range of circumstances, including post operative recovery, accident and emergency, stroke and cardiac events.

A respiratory rate counter is being developed that will give healthcare professionals an early indication of the change in the condition of patient.

Lung Cancer Screening

Lung cancer is the leading cause of cancer death in the United States. The overall 5 year survival rate of lung cancer patients are approximately 16%. A recent study of 150 subjects demonstrated that the Lung Cancer Screening device detected already diagnosed lung cancer reliably and identified undiagnosed lung cancer in the target population.

The device has the potential to provide a low cost, safe screening tool for lung cancer at a primary care level potentially enabling earlier intervention and improving survivability.

Asthma and COPD diagnosis

Our Asthma Alert device is being developed for asthma and COPD diagnosis. Asthma Alert utilises proprietary sensor technology that analyses the pattern of breathing detecting asthma and COPD. It does not require forced expiration but requires only normal tidal breathing, offering substantial advantages over spirometry and peak flow measurements.

A clinical study undertaken at Charing Cross Hospital demonstrated good correlation between the results of the breath analysis with clinical evaluation and spiromertry. Patients appreciated the normal tidal breathing and Professor Martyn Partridge reported that Asthma Alert is “so easy to use”

Asthma management

A monitoring device is being developed for asthma management. The monitoring device will provide a patient with their current asthma status and short term and long term trends, indicating any deterioration in their condition. This information may be used to manage asthma more effectively, since asthma patients tend to accommodate their asthma and slow deteriorations in disease status can go unnoticed leading to sub optimal management.

Sleep Apnoea

The Anaxsys Technology sensor has been shown to be able to measure breathing patterns that have potential application to the diagnosis of sleep apnoea. A product is being developed in conjunction with leading clinicians in sleep apnoea.

Valid CSS :: Valid XHTML Copyright © 2010 Anaxsys Technology.